Works matching AU Christophe, Borg

Results: 93
    1
    2

    Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice.

    Published in:
    Quality of Life Research, 2021, v. 30, n. 11, p. 3255, doi. 10.1007/s11136-020-02721-0
    By:
    • Mouillet, Guillaume;
    • Falcoz, Antoine;
    • Fritzsch, Joëlle;
    • Almotlak, Hamadi;
    • Jacoulet, Pascale;
    • Pivot, Xavier;
    • Villanueva, Cristian;
    • Mansi, Laura;
    • Kim, Stefano;
    • Curtit, Elsa;
    • Meneveau, Nathalie;
    • Adotevi, Olivier;
    • Jary, Marine;
    • Eberst, Guillaume;
    • Vienot, Angelique;
    • Calcagno, Fabien;
    • Pozet, Astrid;
    • Djoumakh, Oumelkheir;
    • Borg, Christophe;
    • Westeel, Virginie
    Publication type:
    Article
    3
    4
    5
    6
    7

    Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruption.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-01962-6
    By:
    • Lopez, Morgane;
    • Spehner, Laurie;
    • André, Fabrice;
    • Viot, Julien;
    • Seffar, Evan;
    • Marguier, Amélie;
    • Curtit, Elsa;
    • Meynard, Guillaume;
    • Dobi, Erion;
    • Ladoire, Sylvain;
    • Boidot, Romain;
    • Loyon, Romain;
    • Derangere, Valentin;
    • Bidard, François-Clément;
    • Borg, Christophe;
    • Mansi, Laura;
    • Kroemer, Marie
    Publication type:
    Article
    8
    9

    Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study.

    Published in:
    Molecular Oncology, 2022, v. 16, n. 11, p. 2260, doi. 10.1002/1878-0261.13173
    By:
    • Jary, Marine;
    • Wen-Wei Liu;
    • Dongyao Yan;
    • Bai, Isaac;
    • Muranyi, Andrea;
    • Colle, Elise;
    • Brocheriou, Isabelle;
    • Turpin, Anthony;
    • Radosevic-Robin, Nina;
    • Bourgoin, Pierre;
    • Penault-Llorca, Frédérique;
    • Cohen, Romain;
    • Vernerey, Dewi;
    • André, Thierry;
    • Borg, Christophe;
    • Shanmugam, Kandavel;
    • Svrcek, Magali
    Publication type:
    Article
    10

    Biomarqueurs actuels et à venir dans les cancers œsogastriques.

    Published in:
    Hépato-Gastro & Oncologie Digestive, 2023, v. 30, p. 7, doi. 10.1684/hpg.2023.2630
    By:
    • Bibeau, Frédéric;
    • Monnien, Franck;
    • Laydi, Maxime;
    • Mathieu, Pierre;
    • Viennot, Angélique;
    • Viot, Julien;
    • Borg, Christophe;
    • Overs, Alexis;
    • Molimard, Chloé
    Publication type:
    Article
    11

    Prise en charge du carcinome épidermoïde avancé du canal anal.

    Published in:
    Hépato-Gastro & Oncologie Digestive, 2020, v. 27, n. 9, p. 873, doi. 10.1684/hpg.2020.2025
    By:
    • Stouvenot, Morgane;
    • Vuitton, Lucine;
    • Meurisse, Aurélia;
    • Spehner, Laurie;
    • Jacquin, Marion;
    • Fein, Francine;
    • Klajer, Élodie;
    • Vienot, Angélique;
    • Boulbair, Fatiha;
    • Pernot, Mandy;
    • Jary, Marine;
    • Borg, Christophe;
    • Kim, Stefano
    Publication type:
    Article
    12

    Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.

    Published in:
    British Journal of Cancer, 2024, v. 130, n. 3, p. 442, doi. 10.1038/s41416-023-02524-3
    By:
    • Flecchia, Clémence;
    • Auclin, Edouard;
    • Alouani, Emily;
    • Mercier, Mathilde;
    • Hollebecque, Antoine;
    • Turpin, Anthony;
    • Mazard, Thibault;
    • Pernot, Simon;
    • Dutherage, Marie;
    • Cohen, Romain;
    • Borg, Christophe;
    • Hautefeuille, Vincent;
    • Sclafani, Francesco;
    • Ben-Abdelghani, Meher;
    • Aparicio, Thomas;
    • De La Fouchardière, Christelle;
    • Herve, Camille;
    • Perkins, Geraldine;
    • Heinrich, Kathrin;
    • Kunzmann, Volker
    Publication type:
    Article
    13

    Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial.

    Published in:
    Journal of Translational Medicine, 2005, v. 3, p. 10, doi. 10.1186/1479-5876-3-10
    By:
    • Escudier, Bernard;
    • Dorval, Thierry;
    • Chaput, Nathalie;
    • André, Fabrice;
    • Caby, Marie-Pierre;
    • Novault, Sophie;
    • Flament, Caroline;
    • Leboulaire, Christophe;
    • Borg, Christophe;
    • Amigorena, Sebastian;
    • Boccaccio, Catherine;
    • Bonnerot, Christian;
    • Dhellin, Olivier;
    • Movassagh, Mojgan;
    • Piperno, Sophie;
    • Robert, Caroline;
    • Serra, Vincent;
    • Valente, Nancy;
    • Le Pecq, Jean-Bernard;
    • Spatz, Alain
    Publication type:
    Article
    14
    15
    16
    17
    18
    19

    The NHance ® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients.

    Published in:
    Biomedicines, 2021, v. 9, n. 6, p. 665, doi. 10.3390/biomedicines9060665
    By:
    • Aftimos, Philippe;
    • Rolfo, Christian;
    • Rottey, Sylvie;
    • Barthélémy, Philippe;
    • Borg, Christophe;
    • Park, Keunchil;
    • Oh, Do-Youn;
    • Kim, Sang-We;
    • De Jonge, Natalie;
    • Hanssens, Valérie;
    • Zwanenpoel, Karen;
    • Molthoff, Carla;
    • Vugts, Daniëlle;
    • Dreier, Torsten;
    • Verheesen, Peter;
    • van Dongen, Guus A.M.S.;
    • Jacobs, Julie;
    • Van Rompaey, Luc;
    • Hultberg, Anna;
    • Michieli, Paolo
    Publication type:
    Article
    20

    Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trial.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 01, doi. 10.3389/fonc.2022.941676
    By:
    • Debernardi, Alice;
    • Meurisse, Aurélia;
    • Prétet, Jean-Luc;
    • Guenat, David;
    • Monnien, Franck;
    • Spehner, Laurie;
    • Vienot, Angélique;
    • Roncarati, Patrick;
    • André, Thierry;
    • Abramowitz, Laurent;
    • Molimard, Chloé;
    • Mougin, Christiane;
    • Herfs, Michael;
    • Kim, Stefano;
    • Borg, Christophe
    Publication type:
    Article
    21

    Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mDCF (docetaxel, cisplatin, and 5-fluorouracil) followed by chemoradiotherapy in patients with Stage III squamous cell anal carcinoma.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.918499
    By:
    • Kim, Stefano;
    • Boustani, Jihane;
    • Vernerey, Dewi;
    • Vendrely, Vèronique;
    • Evesque, Ludovic;
    • Francois, Eric;
    • Quero, Laurent;
    • Ghiringhelli, Francois;
    • de la Fouchardière, Christelle;
    • Dahan, Laëtitia;
    • Bouche´, Oliver;
    • Chibaudel, Benoist;
    • Hajbi, Farid El;
    • Vernet, Chloè;
    • Rebucci-Peixoto, Magali;
    • Feuersinger, Alexandra;
    • Maritaz, Christophe;
    • Borg, Christophe
    Publication type:
    Article
    22
    23

    EMT is associated with an epigenetic signature of ECM remodeling genes.

    Published in:
    Cell Death & Disease, 2019, v. 10, n. 3, p. 1, doi. 10.1038/s41419-019-1397-4
    By:
    • Peixoto, Paul;
    • Etcheverry, Amandine;
    • Aubry, Marc;
    • Missey, Anaïs;
    • Lachat, Camille;
    • Perrard, Jérôme;
    • Hendrick, Elodie;
    • Delage-Mourroux, Régis;
    • Mosser, Jean;
    • Borg, Christophe;
    • Feugeas, Jean-Paul;
    • Herfs, Michaël;
    • Boyer-Guittaut, Michaël;
    • Hervouet, Eric
    Publication type:
    Article
    24

    DNA damage response defect in Williams-Beuren syndrome.

    Published in:
    International Journal of Molecular Medicine, 2017, v. 39, n. 3, p. 622, doi. 10.3892/ijmm.2017.2861
    By:
    • GUENAT, DAVID;
    • MERLA, GIUSEPPE;
    • DECONINCK, ERIC;
    • BORG, CHRISTOPHE;
    • ROHRLICH, PIERRE-SIMON
    Publication type:
    Article
    25
    26
    27

    Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study.

    Published in:
    2019
    By:
    • Borg, Christophe;
    • Mantion, Georges;
    • Boudghene, Frank;
    • Mornex, Fran<;oise;
    • Ghiringhelli, Francois;
    • Adenis, Antoine;
    • Azria, David;
    • Balosso, Jacques;
    • Abdelghani, Meher Ben;
    • Bachet, Jean Baptiste;
    • Vendrely, Veronique;
    • Francois, Yves;
    • Conroy, Thierry;
    • Rio, Emmanuel;
    • Roullet, Bernard;
    • Spaeth, Dominique;
    • Quero, Laurent;
    • Lakkis, Zaher;
    • Coudert, Mathieu;
    • Ionescu-Goga, Miruna
    Publication type:
    journal article
    28
    29

    Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study.

    Published in:
    BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2860-6
    By:
    • d'Engremont, Christelle;
    • Vernerey, Dewi;
    • Pointet, Anne-Laure;
    • Simone, Gaël;
    • Fein, Francine;
    • Heyd, Bruno;
    • Koch, Stéphane;
    • Vuitton, Lucine;
    • Kim, Stefano;
    • Jary, Marine;
    • Lamfichek, Najib;
    • Turco, Celia;
    • Lakkis, Zaher;
    • Berger, Anne;
    • Bonnetain, Franck;
    • Taieb, Julien;
    • Bachellier, Philippe;
    • Borg, Christophe
    Publication type:
    Article
    30

    Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4<sup>+</sup>CD25<sup>high</sup>FOXP3<sup>+</sup> Regulatory T Cells.

    Published in:
    Stem Cells, 2008, v. 26, n. 1, p. 212, doi. 10.1634/stemcells.2007-0554
    By:
    • SELMANI, ZOHAIR;
    • NAJI, ABDERRAHIM;
    • ZIDI, INES;
    • FAVIER, BENOIT;
    • GAIFFE, EMILIE;
    • OBERT, LAURENT;
    • BORG, CHRISTOPHE;
    • SAAS, PHILIPPE;
    • TIBERGHIEN, PIERRE;
    • ROUAS-FREISS, NATHALIE;
    • CAROSELLA, EDGARDO D.;
    • DESCHASEAUX, FREDERIC
    Publication type:
    Article
    31

    Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha‐fetoprotein after sorafenib in REACH and REACH‐2.

    Published in:
    Liver International, 2020, v. 40, n. 8, p. 2008, doi. 10.1111/liv.14462
    By:
    • Kudo, Masatoshi;
    • Galle, Peter R.;
    • Llovet, Josep M.;
    • Finn, Richard S.;
    • Vogel, Arndt;
    • Motomura, Kenta;
    • Assenat, Eric;
    • Merle, Philippe;
    • Brandi, Giovanni;
    • Daniele, Bruno;
    • Okusaka, Takuji;
    • Tomášek, Jiří;
    • Borg, Christophe;
    • Dadduzio, Vincenzo;
    • Morimoto, Manabu;
    • Pracht, Marc;
    • Jen, Min‐Hua;
    • Drove Ubreva, Nora;
    • Widau, Ryan C.;
    • Shinozaki, Kenta
    Publication type:
    Article
    32

    X-CHROMOSOME GENETICS AND HUMAN CANCER

    Published in:
    Nature Reviews Cancer, 2004, v. 4, n. 8, p. 617, doi. 10.1038/nrc1413
    By:
    • Spatz, Alain;
    • Borg, Christophe;
    • Feunteun, Jean
    Publication type:
    Article
    33
    34

    Molecular description of ANGPT2 associated colorectal carcinoma.

    Published in:
    International Journal of Cancer, 2020, v. 147, n. 7, p. 2007, doi. 10.1002/ijc.32993
    By:
    • Jary, Marine;
    • Hasanova, Reyhan;
    • Vienot, Angélique;
    • Asgarov, Kamal;
    • Loyon, Romain;
    • Tirole, Charline;
    • Bouard, Adeline;
    • Orillard, Emeline;
    • Klajer, Elodie;
    • Kim, Stefano;
    • Viot, Julien;
    • Colle, Elise;
    • Adotevi, Olivier;
    • Bouché, Olivier;
    • Lecomte, Thierry;
    • Borg, Christophe;
    • Feugeas, Jean P.
    Publication type:
    Article
    35
    36
    37
    38

    Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance.

    Published in:
    Gastric Cancer, 2020, v. 23, n. 1, p. 73, doi. 10.1007/s10120-019-00983-3
    By:
    • Pernot, Simon;
    • Terme, Magali;
    • Radosevic-Robin, Nina;
    • Castan, Florence;
    • Badoual, Cécile;
    • Marcheteau, Elie;
    • Penault-Llorca, Fréderique;
    • Bouche, Olivier;
    • Bennouna, Jaafar;
    • Francois, Eric;
    • Ghiringhelli, Francois;
    • De La Fouchardiere, Christelle;
    • Samalin, Emmanuelle;
    • Baptiste Bachet, Jean;
    • Borg, Christophe;
    • Boige, Valérie;
    • Voron, Thibault;
    • Stanbury, Trevor;
    • Tartour, Eric;
    • Gourgou, Sophie
    Publication type:
    Article
    39

    Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study.

    Published in:
    Gastric Cancer, 2019, v. 22, n. 4, p. 828, doi. 10.1007/s10120-018-00909-5
    By:
    • Bang, Yung-Jue;
    • Kang, Yoon-Koo;
    • Catenacci, Daniel V.;
    • Muro, Kei;
    • Fuchs, Charles S.;
    • Geva, Ravit;
    • Hara, Hiroki;
    • Golan, Talia;
    • Garrido, Marcelo;
    • Jalal, Shadia I.;
    • Borg, Christophe;
    • Doi, Toshihiko;
    • Yoon, Harry H.;
    • Savage, Mary J.;
    • Wang, Jiangdian;
    • Dalal, Rita P.;
    • Shah, Sukrut;
    • Wainberg, Zev A.;
    • Chung, Hyun Cheol
    Publication type:
    Article
    40

    Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 141, doi. 10.1007/s00280-014-2482-0
    By:
    • Jary, Marine;
    • Ghiringhelli, Francois;
    • Jacquin, Marion;
    • Fein, Francine;
    • Nguyen, Thierry;
    • Cleau, Denis;
    • Nerich, Virginie;
    • El Gani, Maryame;
    • Mathieu, Pierre;
    • Valmary-Degano, Séverine;
    • Arnould, Laurent;
    • Lassabe, Catherine;
    • Lamfichekh, Najib;
    • Fratté, Serge;
    • Paget-Bailly, Sophie;
    • Bonnetain, Franck;
    • Borg, Christophe;
    • Kim, Stefano
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    A new anti-mesothelin antibody targets selectively the membrane-associated form.

    Published in:
    mAbs (1942-0862), 2017, v. 9, n. 3, p. 567, doi. 10.1080/19420862.2017.1288770
    By:
    • Asgarov, Kamal;
    • Balland, Jeremy;
    • Tirole, Charline;
    • Bouard, Adeline;
    • Mougey, Virginie;
    • Ramos, Diana;
    • Barroso, António;
    • Zangiacomi, Vincent;
    • Jary, Marine;
    • Kim, Stefano;
    • Gonzalez-Pajuelo, Maria;
    • Royer, Bernard;
    • de Haard, Hans;
    • Clark, Andy;
    • Wijdenes, John;
    • Borg, Christophe
    Publication type:
    Article
    47
    48
    49

    Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07593-7
    By:
    • Selmani, Zohair;
    • Molimard, Chloé;
    • Overs, Alexis;
    • Bazan, Fernando;
    • Chaigneau, Loic;
    • Dobi, Erion;
    • Meneveau, Nathalie;
    • Mansi, Laura;
    • Paillard, Marie-Justine;
    • Meynard, Guillaume;
    • Viot, Julien;
    • Algros, Marie-Paule;
    • Borg, Christophe;
    • Feugeas, Jean-Paul;
    • Pivot, Xavier;
    • Prétet, Jean-Luc;
    • Curtit, Elsa
    Publication type:
    Article
    50